The latest prostate cancer news
Study predicts lethal prostate cancer risk using genetic scores
Researchers at University of California San Diego School of Medicine, USA, with colleagues elsewhere, report…
Browsing: Prostate Cancer
ASTRO 2022: Lower prostate cancer screening rates associated with subsequent increase in advanced cancers
In the face of conflicting evidence over the risks and benefits of routine prostate cancer…
New epigenetic markers for prostate cancer discovered
New epigenetic biomarkers to predict more aggressive forms of prostate cancer have been discovered by…
Researchers identify drug resistance factors for advanced prostate cancer
The advent of small-molecule targeted therapies, a decade ago, revolutionised the treatment of metastatic melanoma,…
Research suggests commonly used prostate cancer treatment rewires engine of prostate tumours
Drugs like enzalutamide that inhibit male hormones from activating the androgen receptor have been used…
New research shows PSMA PET/CT imaging changes management for close to 50% of prostate cancer patients
In prostate cancer patients experiencing recurrence following a radical prostatectomy, imaging with 18F-DCFPyL PSMA PET/CT…
ESMO 2022: Highlights on ADT duration with post-operative radiotherapy in prostate cancer: RADICALS-HD
Stress granules may drive obesity-associated pancreatic cancer
Obesity is a known risk factor for at least 13 types of cancer, in part because…
Mechanism causing prostate cancer hypoxia and tumour progression identified
A Northwestern Medicine study (USA) has identified a molecular mechanism that helps regulate the progression…
ICR criticises NICE rejection of olaparib for advanced prostate cancer
The Institute of Cancer Research, London, has expressed disappointment that NICE has confirmed its decision…